Oppenheimer Asset Management Inc. Acquires New Holdings in Transcat, Inc. $TRNS

Posted by Geri Gentry on Aug 17th, 2026

Oppenheimer Asset Management Inc. bought a new stake in Transcat, Inc. (NASDAQ:TRNS – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 10,301 shares of the scientific and technical instruments company’s stock, valued at approximately $956,000.

Several other large investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its holdings in shares of Transcat by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 530,771 shares of the scientific and technical instruments company’s stock valued at $38,852,000 after purchasing an additional 2,041 shares in the last quarter. Royce & Associates LP boosted its holdings in Transcat by 15.3% in the fourth quarter. Royce & Associates LP now owns 390,546 shares of the scientific and technical instruments company’s stock worth $22,156,000 after purchasing an additional 51,774 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Transcat by 3.7% in the first quarter. Dimensional Fund Advisors LP now owns 262,033 shares of the scientific and technical instruments company’s stock worth $19,244,000 after purchasing an additional 9,266 shares in the last quarter. Wellington Management Group LLP increased its position in Transcat by 677.7% during the fourth quarter. Wellington Management Group LLP now owns 248,539 shares of the scientific and technical instruments company’s stock worth $14,100,000 after buying an additional 216,579 shares during the last quarter. Finally, Bamco Inc. NY increased its position in Transcat by 6.2% during the fourth quarter. Bamco Inc. NY now owns 203,477 shares of the scientific and technical instruments company’s stock worth $11,543,000 after buying an additional 11,911 shares during the last quarter. 98.34% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have weighed in on TRNS. Wall Street Zen upgraded Transcat from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Northland Securities downgraded Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price target for the company. in a research note on Wednesday, August 5th. Zacks Research raised Transcat from a “strong sell” rating to a “hold” rating in a report on Friday, May 15th. Finally, Weiss Ratings raised Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research note on Thursday, May 28th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $105.50.

Check Out Our Latest Stock Report on TRNS

Insider Activity at Transcat

In other news, Director Christopher P. Gillette sold 504 shares of the company’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $94.23, for a total transaction of $47,491.92. Following the completion of the transaction, the director directly owned 200 shares in the company, valued at $18,846. The trade was a 71.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Craig D. Cairns purchased 1,050 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were acquired at an average price of $93.97 per share, with a total value of $98,668.50. Following the completion of the acquisition, the director owned 1,480 shares of the company’s stock, valued at approximately $139,075.60. The trade was a 244.19% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 1.80% of the company’s stock.

Transcat Stock Performance

Transcat stock opened at $93.70 on Monday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.11 and a current ratio of 2.49. The business’s 50-day simple moving average is $90.05 and its 200-day simple moving average is $80.83. The firm has a market capitalization of $877.03 million, a PE ratio of 253.24 and a beta of 0.68. Transcat, Inc. has a 52 week low of $50.23 and a 52 week high of $100.00.

Transcat (NASDAQ:TRNS – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Transcat had a return on equity of 5.56% and a net margin of 0.99%.The business had revenue of $92.95 million during the quarter, compared to analysts’ expectations of $86.55 million. Equities research analysts forecast that Transcat, Inc. will post 1.74 earnings per share for the current year.

Transcat Profile

(Free Report)

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.